Iranian Firm Makes Topical Gel for Cutaneous Leishmaniasis Treatment
‘Exir Nano Sina’ firm has made the product which is a topical gel based on the nanoliposome technology and its main component is a polyene anti-parasitic and anti-fungal drug.
The gel can be typically used for treating the cutaneous leishmaniasis and has trivial side effects and lower cost.
The encapsulation of the main drug by the nanoliposomal structures has led to promoting the drug penetration into the affected tissue and reducing the detrimental side effects of the drug on the body.
The cream can be used for the treatment of cutaneous leishmaniasis and topical fungal diseases.
Earlier, a knowledge-based company in Iran had also unveiled a new medicine for the treatment of ulcers resulting from the CL disease.
Leish G1 drug was produced as a result of numerous cell, animal and human studies, which is used with new formulation and effective ingredients to treat the wound of the cutaneous leishmaniasis disease.
Cutaneous leishmaniasis is the most common form and causes skin lesions, mainly ulcers, on exposed parts of the body. These can leave life-long scars and cause serious disability or stigma. About 95% of CL cases occur in the Americas, the Mediterranean basin, the Middle East and central Asia.
4155/v
